Pull back likely?
BIB
Similar to its inverse sibling BIS, here's a possible forming H&S top, w/bearish RSI divergence. Again, if/when we crash, expect this to be a big loser!
Biotechs not looking overvalued anymore...
A close below $94 would be bearish
3:1 Risk/Reward
Possible repeat scenario of February
Was asked about this market. Weekly indicates run for cover. Nasty business.
Money going in healthcare and biotechnology - Long term
